Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-06 4:50 pm Purchase |
2025-06-04 | 13D | Tyra Biosciences, Inc. TYRA |
RA CAPITAL MANAGEMENT L.P. | 11,899,788 22.400% |
1,214,898 (+11.37%) |
Filing History |
| 2025-05-15 4:14 pm Purchase |
2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA |
Vestal Point Capital, LP | 2,879,829 5.400% |
2,879,829 (New Position) |
Filing History |
| 2025-05-14 4:05 pm Purchase |
2025-05-07 | 13G | Tyra Biosciences, Inc. TYRA |
Commodore Capital LP | 2,750,000 5.200% |
2,750,000 (New Position) |
Filing History |
| 2025-05-14 11:47 am Purchase |
2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA |
JANUS HENDERSON GROUP PLC JHG |
2,693,237 5.100% |
2,693,237 (New Position) |
Filing History |
| 2025-05-12 10:43 am Sale |
2025-03-31 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 1,707,148 3.200% |
-1,665,702 (-49.39%) |
Filing History |
| 2025-03-31 4:54 pm Purchase |
2025-03-27 | 13D | Tyra Biosciences, Inc. TYRA |
RA CAPITAL MANAGEMENT L.P. | 10,684,890 20.100% |
7,750 (+0.07%) |
Filing History |
| 2025-03-06 6:02 pm Purchase |
2025-02-27 | 13G | Tyra Biosciences, Inc. TYRA |
TCG Crossover GP I, LLC | 2,898,103 5.700% |
2,898,103 (New Position) |
Filing History |
| 2025-02-14 4:24 pm Sale |
2024-12-31 | 13G | Tyra Biosciences, Inc. TYRA |
BIOTECHNOLOGY VALUE FUND L P | 3,944,194 7.800% |
-717,000 (-15.38%) |
Filing History |
| 2025-01-21 4:30 pm Sale |
2024-12-31 | 13G | Tyra Biosciences, Inc. TYRA |
Canaan XI L.P. | 3,731,165 7.400% |
-205,430 (-5.22%) |
Filing History |
| 2024-12-06 9:30 pm Sale |
2024-12-04 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Asset Management Inc. | 2,548,905 5.000% |
-1,522,949 (-37.40%) |
Filing History |
| 2024-11-19 9:31 pm Sale |
2024-11-15 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Asset Management Inc. | 4,071,854 7.700% |
-914,461 (-18.34%) |
Filing History |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA |
NEXTECH VI ONCOLOGY SCSP | 4,055,861 7.700% |
1,537,279 (+61.04%) |
Filing History |
| 2024-11-14 4:34 pm Purchase |
2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA |
BIOTECHNOLOGY VALUE FUND L P | 4,661,194 8.800% |
1,921,599 (+70.14%) |
Filing History |
| 2024-11-13 6:04 pm Purchase |
2024-11-08 | 13D | Tyra Biosciences, Inc. TYRA |
RA CAPITAL MANAGEMENT L.P. | 10,677,140 21.100% |
586,069 (+5.81%) |
Filing History |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 3,372,850 6.387% |
-1,281,426 (-27.53%) |
Filing History |
| 2024-10-22 9:15 pm Purchase |
2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Asset Management Inc. | 4,986,315 9.900% |
4,986,315 (New Position) |
Filing History |
| 2024-10-22 5:11 pm Sale |
2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA |
RA CAPITAL MANAGEMENT L.P. | 10,091,071 19.990% |
-384,418 (-3.67%) |
Filing History |
| 2024-10-15 9:59 pm Purchase |
2024-10-10 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Capital LLC | 6,534,298 12.400% |
85,939 (+1.33%) |
Filing History |
| 2024-10-15 7:22 pm Unchanged |
2024-10-10 | 13D | Tyra Biosciences, Inc. TYRA |
Boxer Asset Management Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-03-11 08:19 am Purchase |
2024-03-08 | 13G | Tyra Biosciences, Inc. TYRA |
FMR LLC | 4,654,276 10.809% |
1,885,580 (+68.10%) |
Filing History |